Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV TrialOriginal Research · 2025 · 3 citations
2Association of Ertugliflozin on Kidney Outcomes in People After and Without an Interval Cardiovascular Event: Observations From the VERTIS CV Trialcohort · 2026
3Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical TrialsMeta-Analysis · 2024 · 10 citations
4Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) TrialRCT · 2023 · 2 citations
5Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellituscohort · 2022 · 43 citations
6Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from <scp>VERTIS CV</scp> , a randomized trial of the <scp>sodium‐glucose cotransporter‐2</scp> inhibitor ertugliflozinRCT · 2022 · 16 citations
7Heart Failure Outcomes Captured by Adverse Event Reporting in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Observations from the VERTIS CV TrialRCT · 2025 · 3 citations
8Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trialRCT · 2023 · 43 citations
9Continuous Glucose Monitoring in Obesity Without Diabetes: An Unnecessary Gadget or a Gateway to Precision Care?Diabetes Obesity and Metabolism · 2026
10Screening for Nutritional Risk in Adults Receiving Obesity Treatment: A Systematic Literature Review of Available Tools and Identification of Conceptual GapsDiabetes Obesity and Metabolism · 2026

More from Diabetes Obesity and Metabolism

More from Karolinska Institutet